✦ LIBER ✦

A randomized, phase 1/2 trial of the safety, tolerability, and immunogenicity of bivalent rLP2086 meningococcal B vaccine in healthy infants

✍ Scribed by Martinon-Torres, Federico; Gimenez-Sanchez, Francisco; Bernaola-Iturbe, Enrique; Diez-Domingo, Javier; Jiang, Qin; Perez, John L.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase 2 open-label safety and immunoge

✍ Marshall, Helen S.; Richmond, Peter C.; Nissen, Michael D.; Wouters, Ann; Baber, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 633 KB

Safety, immunogenicity, and tolerability

✍ Richmond, Peter C; Marshall, Helen S; Nissen, Michael D; Jiang, Qin; Jansen, Kat 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 293 KB

A Novel Intramuscular Bivalent Norovirus

✍ Treanor, J. J.; Atmar, R. L.; Frey, S. E.; Gormley, R.; Chen, W. H.; Ferreira, J 📂 Article 📅 2014 🏛 University of Chicago Press 🌐 English ⚖ 601 KB

A randomized study comparing the safety

✍ Anna Riddell; Jim P. Buttery; Jodie McVernon; Tracey Chantler; Laura Lane; Jane 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 276 KB

Safety, tolerability and immunogenicity

✍ Gaggar, Anuj; Coeshott, Claire; Apelian, David; Rodell, Timothy; Armstrong, Bria 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 725 KB

Safety and preliminary immunogenicity of

✍ Dotres, Carlos P.; Puga, Rinaldo; Ricardo, Yariset; Broño, Carmen R.; Paredes, B 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 303 KB